![Ralf Brandt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ralf Brandt
Director/Board Member at
PROPANC BIOPHARMA, INC.
Net worth: 108 406 $ as of 31/08/2026
Profile
Ralf Brandt was the founder of vivoPharm Pty Ltd., founded in 2003, where the title held was President-Discovery & Early Development.
Current jobs include Director at Propanc Biopharma, Inc. starting in 2026, and Member-Scientific Advisory Board at Receptors, Inc. Former jobs include President-Discovery & Early Development at Cancer Genetics, Inc., Principal at National Cancer Institute, and President-Discovery & Early Development Services at Vyant Bio, Inc. Education includes a doctorate conferred in 1991 and an undergraduate degree conferred in 1986, both from Martin-Luther-Universität Halle-Wittenberg.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 23/09/2026 | 80,301 ( 2.29% ) | 108 406 $ | 31/08/2026 |
Ralf Brandt active positions
| Companies | Position | Start |
|---|---|---|
| PROPANC BIOPHARMA, INC. | Director/Board Member | 20/02/2026 |
Receptors, Inc.
 Receptors, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures electrical equipment and supplies | Corporate Officer/Principal | 02/06/2011 |
Former positions of Ralf Brandt
| Companies | Position | End |
|---|---|---|
| VYANT BIO, INC. | Corporate Officer/Principal | 31/12/2022 |
vivoPharm Pty Ltd.
 vivoPharm Pty Ltd. BiotechnologyHealth Technology Provides proprietary preclinical oncology services | Founder | 01/08/2017 |
| CANCER GENETICS, INC. | Corporate Officer/Principal | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Training of Ralf Brandt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
18
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Propanc Biopharma, Inc.
 Propanc Biopharma, Inc. BiotechnologyHealth Technology Operates as a development stage healthcare company which develops new cancer treatments for patients | Health Technology |
Receptors, Inc.
Receptors, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures electrical equipment and supplies | Electronic Technology |
Cancer Genetics, Inc.
 Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Provides cancer diagnostics and clinical services | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Martin-Luther-Universität Halle-Wittenberg
 Martin-Luther-Universität Halle-Wittenberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vivoPharm Pty Ltd.
vivoPharm Pty Ltd. BiotechnologyHealth Technology Provides proprietary preclinical oncology services | Health Technology |
Vyant Bio, Inc.
 Vyant Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
- Stock Market
- Insiders
- Ralf Brandt
